Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints
27 August 2021 (08:00 - 20:00)
Organised by:
Slides
About the speaker
Icahn School of Medicine at Mount Sinai, New York City (United States of America)
6 More presentations in this session
Doctor C. Gyldenkerne (Aarhus, DK)
Professor C. Antoniades (Oxford, GB)
Doctor H. Jorstad (Amsterdam, NL)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August 2021
08:00 CET
